2022
DOI: 10.1053/j.gastro.2022.07.016
|View full text |Cite
|
Sign up to set email alerts
|

SMAD4 Suppresses Colitis-associated Carcinoma Through Inhibition of CCL20/CCR6-mediated Inflammation

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
15
1

Year Published

2023
2023
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 22 publications
(17 citation statements)
references
References 49 publications
1
15
1
Order By: Relevance
“…The transcriptome of peripheral blood monocytes exposed to acute heat exposure had an inflammatory signature consisting of chemokines (C‐C motif ligand, C‐X‐C motif ligand, interleukin), complement C1qA chain, IFN‐γ, TNF, NLRP3, and colony‐stimulating factor 3. Accumulating evidence indicates that multiple inflammatory cytokines such as TNF‐α, IFN‐γ, CCL20, IL1, and IL6 induce inflammation (Dinarello, 2011; Hanna et al., 2022; Jones & Jenkins, 2018; Karki et al., 2021). C1qA, the initiating molecule of the classical complement cascade, can trigger inflammation, and blocking C1q function reduces chronic glial inflammation and neuron loss (Holden et al., 2021).…”
Section: Discussionmentioning
confidence: 99%
“…The transcriptome of peripheral blood monocytes exposed to acute heat exposure had an inflammatory signature consisting of chemokines (C‐C motif ligand, C‐X‐C motif ligand, interleukin), complement C1qA chain, IFN‐γ, TNF, NLRP3, and colony‐stimulating factor 3. Accumulating evidence indicates that multiple inflammatory cytokines such as TNF‐α, IFN‐γ, CCL20, IL1, and IL6 induce inflammation (Dinarello, 2011; Hanna et al., 2022; Jones & Jenkins, 2018; Karki et al., 2021). C1qA, the initiating molecule of the classical complement cascade, can trigger inflammation, and blocking C1q function reduces chronic glial inflammation and neuron loss (Holden et al., 2021).…”
Section: Discussionmentioning
confidence: 99%
“…Previous studies used haploinsufficiency 71 , or partial deletion 23 , of Smad4 loss in the epithelium and show that Smad4 loss promotes colitis and colitis-associated cancer 23, 24 . Furthermore, in contrast to previous studies that used DSS-IBD mouse models of chronic inflammation, our study employed a model of acute inflammation 23,24,70 . However, given the role of Smad4 in genomic stability 21, 22, 72 and tumor suppression 16, 17 , it is not surprising that Smad4 loss led to tumorigenesis in the chronic inflammatory DSS-IBD mouse model, especially in the presence of a DNA-damaging agent such as AOM.…”
Section: Discussionmentioning
confidence: 99%
“…Smad4, a central signalling component of transforming growth factor β (TGF‐β), is a multifunctional cytokine that regulates cell growth and differentiation 15–17 . Smad4 was regarded as an important tumour suppressor in various types of cancers 18–21 . The role of Smad4 as a tumour suppressor was initially identified in pancreatic cancer as being absent in pancreatic cancer 4 (DPC4)4, 22–24 and since then loss of Smad4 has been identified in a key driver in skin cancer, 25 head and neck cancer, 26 and other cancers 16,19 .…”
Section: Introductionmentioning
confidence: 99%
“…[18][19][20][21] The role of Smad4 as a tumour suppressor was initially identified in pancreatic cancer as being absent in pancreatic cancer 4 (DPC4)4, [22][23][24] and since then loss of Smad4 has been identified in a key driver in skin cancer, 25 head and neck cancer, 26 and other cancers. 16,19 Epithelial deficiency of Smad4 could lead to overexpression of TGFβ which then was released into the tumour microenvironment to promote squamous carcinoma progression through pro-inflammatory and immune evasion mechanisms. 19,27,28 However, mechanisms governing dysregulation of Smad4 in OSCC was unclear.…”
mentioning
confidence: 99%
See 1 more Smart Citation